Xiuxiu Zhang

Xiuxiu Zhang

Auto-generated profile, based on publicly available information

Xiuxiu Zhang

School of Medicine, Southeast University, Nanjing 210009, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2022 in International Journal of Biological Sciences
Verified
Journal Article
Open access
XGXuyu Gu
Xuyu Gu
XHXianting Huang
Xianting Huang
XZXiuxiu Zhang
Xiuxiu Zhang
CWCailian Wang
Cailian Wang
Background: A significant factor influencing the prognosis of lung adenocarcinoma (LUAD) is tumor metastasis. Studies have shown that abnormal DNA methylation in circulating tumor cells (CTCs) is associated with tumour metastasis. Based on the genes expressed in CTCs that play an important role in DNA methylation, we hope to build a risk model to predict prognosis and provide a therapeutic strategy in LUAD.

9 November 2021 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
PDF file
MZMin Zhou
Min Zhou
XZXiuxiu Zhang
Xiuxiu Zhang
TLTianyang Li
Tianyang Li
YCYan Chen
Yan Chen
Background: Ferroptosis is an iron‐dependent programmed cell death mechanism that influences the development of malignancy. Lung adenocarcinoma (LUAD) is the most common type of lung cancer with no known cure. Anti–PD‐1/PD‐L immunotherapy is effective for patients with partial LUAD. Therefore, there is an immediate requirement of novel markers to predict the individualised benefits of immunotherapy.Methods: We manually collected the ferroptosis‐related gene (FERG) set and employed the Wilcoxon rank‐sum test to identify the differentially expressed FERGs. Subsequently, we constructed a recursive partitioning and regression tree (RPART) model to predict the benefits of anti–PD‐1/PD‐L1 immunotherapy. Subsequently, the ROC curve and AUC were used to evaluate the model efficiency in an independent dataset.Results: In this study, we found that the dysregulated FERGs were closely associated with multiple metabolic processes in LUAD. Furthermore, we identified three ferroptosis‐related tumour subtypes (F1, F3 and F3). The F3 subtype exhibited higher immunoactivity and lower tumour purity, mutation count and aneuploidy and had better survival outcomes compared with the other two subtypes, implying that FERGs played an important role in intertumoral immune heterogeneity. We further explored the role of FERGs in the anti–PD‐1/PD‐L1 immunotherapy. We identified a set of three‐FERGs signature (CD44, G6PD and ZEB1) that acted as a promising indicator (AUC = 0.697) for the prediction of the benefits of anti–PD‐1/PD‐L1 immunotherapy.Conclusion: Ferroptosis, as emerging programmed cell death mechanism, was associated with cancer development. We used ferroptosis‐related genes to predict the immunotherapy benefits that may facilitate the development of individualised anti‐cancer treatment strategies.

1 January 2021 in Clinics
Verified
Journal Article
Open access
XZXiuxiu Zhang
Xiuxiu Zhang
XLXin Liu
Xin Liu
RCRui Chang
Rui Chang
YLYue Li
Yue Li
To investigate the role of miR-139-5p and the TLR4/MyD88/NF-κB signaling pathway in acute lung injury in septic mice. A total of 140 healthy male SPF C57BL/6 mice were divided into seven groups, i.e., Normal, Control, NC, miR-139-5p mimic, miR-139-5p inhibitor, TAK-242, and miR-139-5p inhibitor+TAK-242 groups. The levels of miR-139-5p, proteins related to the TLR4/MyD88/NF-κB signaling pathway (TLR4, MyD88, and p-NF-κB p50), and MPO, SOD, GSH, and MDA in lung tissue were measured. The lung tissue wet-to-dry mass ratio (W/D), arterial oxygen partial pressure (PaO2), and carbon dioxide partial pressure (PaCO2) were measured. A web-based bioinformatic tool predicted that MyD88 was a target of miR-139-5p, which was verified by a dual luciferase reporter assay. Compared with those in the Normal group, the levels of miR-139-5p, PaO2, SOD, and GSH were significantly lower, while those of TLR4, MyD88, p-NF-κB p50, W/D, PaCO2, IL-1β, TNF-α, IL-6, MPO, and MDA were higher in all other groups. Moreover, compared with their levels in the Control group, these indicators exhibited contrasting results in the miR-139-5p mimic and TAK-242 groups, but were similar in the miR-139-5p inhibitor group. In the miR-139-5p inhibitor+TAK-242 group, acute lung injury, aggravated by miR-139-5p inhibitor, was partially rescued by TAK-242. miR-139-5p inhibits the TLR4/MyD88/NF-κB signaling pathway to alleviate acute lung injury in septic mice.